Apyx Medical Corporation (APYX)

Market Cap	49.13M
Revenue (ttm)	48.10M
Net Income (ttm)	-23.46M
Shares Out	37.79M
EPS (ttm)	-0.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,944
Open	1.270
Previous Close	1.310
Day's Range	1.160 - 1.380
52-Week Range	0.930 - 1.990
Beta	1.18
Analysts	Hold
Price Target	n/a
Earnings Date	Mar 13, 2025

About APYX

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company’s Helium Plasma Technology products are marketed and sold under the Renuvion name in the c...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jan 1, 1987
• Employees: 220
• Stock Exchange: NASDAQ
• Ticker Symbol: APYX
• Website: https://apyxmedical.com

Financial Performance

In 2024, Apyx Medical's revenue was $48.10 million, a decrease of -8.11% compared to the previous year's $52.35 million. Losses were -$23.46 million, 25.4% more than in 2023.